Myriad Genetics Inc
XHAM:MYD

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
XHAM:MYD
Watchlist
Price: 5.55 EUR -3.48% Market Closed
Market Cap: 498.9m EUR

Wall Street
Price Targets

MYD Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYD is 6.97 EUR with a low forecast of 3 EUR and a high forecast of 16.01 EUR.

Lowest
Price Target
3 EUR
46% Downside
Average
Price Target
6.97 EUR
26% Upside
Highest
Price Target
16.01 EUR
189% Upside
Myriad Genetics Inc Competitors:
Price Targets
9966
Alphamab Oncology
2% Downside
ORGO
Organogenesis Holdings Inc
48% Upside
VNDA
Vanda Pharmaceuticals Inc
73% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
2157
Lepu Biopharma Co Ltd
106% Upside
SERA
Sera Prognostics Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Myriad Genetics Inc

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

7%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Myriad Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYD's stock price target?
Price Target
6.97 EUR

According to Wall Street analysts, the average 1-year price target for MYD is 6.97 EUR with a low forecast of 3 EUR and a high forecast of 16.01 EUR.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

Back to Top